<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-03738</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0002278</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Nephrology/Acute Renal Failure</subject><subject>Nephrology/Chronic Kidney Disease</subject></subj-group></article-categories><title-group><article-title>Metalloprotease Meprin&#x003b2; in Rat Kidney: Glomerular Localization and Differential Expression in Glomerulonephritis</article-title><alt-title alt-title-type="running-head">Meprin&#x003b2; in Glomerular Disease</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Oneda</surname><given-names>Beatrice</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lods</surname><given-names>Nad&#x000e8;ge</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lottaz</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000a4;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Becker-Pauly</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>St&#x000f6;cker</surname><given-names>Walter</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pippin</surname><given-names>Jeffrey</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huguenin</surname><given-names>Maya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ambort</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marti</surname><given-names>Hans-Peter</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sterchi</surname><given-names>Erwin E.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Institute of Biochemistry and Molecular Medicine, University of Bern, Bern, Switzerland</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Institute of Zoology, Johannes Gutenberg University, Mainz, Germany</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Division of Nephrology, University of Washington, Seattle, Washington, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Division of Nephrology/Hypertension, Inselspital, University of Bern, Bern, Switzerland</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Bozza</surname><given-names>Patricia</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Instituto Oswaldo Cruz and FIOCRUZ, Brazil</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>erwin.sterchi@mci.unibe.ch</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: ES. Performed the experiments: BO NL CB JP. Analyzed the data: ES BO NL DL CB WS JP. Contributed reagents/materials/analysis tools: NL WS JP. Wrote the paper: BO. Other: Discussed manuscript with first author: ES. Wrote part of the paper: ES. Discussed results and read/edited manuscript: MH HM DA. Edited/corrected manuscript: ES.</p></fn><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Department of Rheumatology and Clinical Immunology, Inselspital, University of Bern, Bern, Switzerland</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>28</day><month>5</month><year>2008</year></pub-date><volume>3</volume><issue>5</issue><elocation-id>e2278</elocation-id><history><date date-type="received"><day>25</day><month>2</month><year>2008</year></date><date date-type="accepted"><day>17</day><month>4</month><year>2008</year></date></history><copyright-statement>Oneda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Meprin (EC 3.4.24.18) is an oligomeric metalloendopeptidase found in microvillar membranes of kidney proximal tubular epithelial cells. Here, we present the first report on the expression of meprin&#x003b2; in rat glomerular epithelial cells and suggest a potential involvement in experimental glomerular disease. We detected meprin&#x003b2; in glomeruli of immunostained rat kidney sections on the protein level and by quantitative RT-PCR of laser-capture microdissected glomeruli on the mRNA level. Using immuno-gold staining we identified the membrane of podocyte foot processes as the main site of meprin&#x003b2; expression. The glomerular meprin&#x003b2; expression pattern was altered in anti-Thy 1.1 and passive Heymann nephritis (PHN). In addition, the meprin&#x003b2; staining pattern in the latter was reminiscent of immunostaining with the sheep anti-Fx1A antiserum, commonly used in PHN induction. Using Western blot and immunoprecipitation assays we demonstrated that meprin&#x003b2; is recognized by Fx1A antiserum and may therefore represent an auto-antigen in PHN. In anti-Thy 1.1 glomerulonephritis we observed a striking redistribution of meprin&#x003b2; in tubular epithelial cells from the apical to the basolateral side and the cytosol. This might point to an involvement of meprin&#x003b2; in this form of glomerulonephritis.</p></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Many forms of inflammatory kidney disease are characterized by excessive proliferation of mesangial cells (MC) and by increased deposition of extracellular matrix (ECM) in glomeruli and the tubulo-interstitium, with subsequent structural alteration of the glomerular basement membrane (GBM) and the mesangial matrix <xref ref-type="bibr" rid="pone.0002278-Johnson1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Akagi1">&#x0005b;2&#x0005d;</xref>. Therefore, an analysis of the factors responsible for the regulation of MC proliferation and for the metabolism of ECM is of highest priority. The processing of ECM proteins in the kidney is influenced substantially by members of the metzincin superfamily of metalloendopeptidases, notably by the matrix metalloproteases (MMPs) <xref ref-type="bibr" rid="pone.0002278-Lovett1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Marti1">&#x0005b;5&#x0005d;</xref> and by the ADAMs (a disintegrin and metalloprotease) <xref ref-type="bibr" rid="pone.0002278-Killar1">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Duffy1">&#x0005b;7&#x0005d;</xref>. The role of MMPs in basement membrane remodelling in particular has recently received a lot of attention due to their ability to influence the progression of renal dysfunction <xref ref-type="bibr" rid="pone.0002278-Rao1">&#x0005b;8&#x0005d;</xref>. Moreover, the pharmacological ablation of MMP enzymatic activity in a mouse model of Alport syndrome prior to the onset of proteinuria or structural defects of the GBM led to significant attenuation in disease progression and to prolonged survival <xref ref-type="bibr" rid="pone.0002278-Zeisberg1">&#x0005b;9&#x0005d;</xref>. Recently, the metalloendopeptidase meprin has been suggested to be involved in these processes, as well <xref ref-type="bibr" rid="pone.0002278-Carmago1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Norman1">&#x0005b;11&#x0005d;</xref>. Meprin (EC 3.4.24.18), an oligomeric zinc endopeptidase of the astacin family, was originally identified on the apical brush-border membrane of epithelial cells in the cortico-medullary portion of proximal kidney tubules and the intestine <xref ref-type="bibr" rid="pone.0002278-Sterchi1">&#x0005b;12&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Sterchi4">&#x0005b;15&#x0005d;</xref>. It is composed of &#x003b1; and &#x003b2; subunits that are expressed separately or coordinately either forming homo- or hetero-oligomeric complexes <xref ref-type="bibr" rid="pone.0002278-Bertenshaw1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Becker1">&#x0005b;17&#x0005d;</xref>. Meprins are highly conserved among different species and are capable of cleaving a wide range of protein substrates <italic>in vitro,</italic> such as ECM components (collagen type IV, laminin, fibronectin and nidogen <xref ref-type="bibr" rid="pone.0002278-Villa1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Walker1">&#x0005b;21&#x0005d;</xref>), cytokines (interleukin-1 &#x003b2;), protein kinases, growth factors and peptide hormones <xref ref-type="bibr" rid="pone.0002278-Bond1">&#x0005b;22&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Choudry1">&#x0005b;27&#x0005d;</xref>. Meprins act extracellularly in that they are either bound to the plasma membrane by transmembrane domains or secreted into the extracellular space <xref ref-type="bibr" rid="pone.0002278-Villa2">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Hengst1">&#x0005b;29&#x0005d;</xref>.</p><p>The role of meprin in the pathogenesis of kidney disease has been studied previously in animal models. There are mouse strains (ICR or C57B1/6) that express both meprin&#x003b1; and &#x003b2; in proximal tubular cells and others (C3H/He or CBA) that exclusively express meprin&#x003b2;, mostly in a latent form (pro-meprin&#x003b2;) with low proteolytic potential <xref ref-type="bibr" rid="pone.0002278-Beynon1">&#x0005b;30&#x0005d;</xref>. When exposed to different renal insults, the latter mice developed less severe forms of kidney disease compared to those with normal meprin levels, suggesting a potential role for meprin in the pathology of acute renal failure <xref ref-type="bibr" rid="pone.0002278-Trachtman1">&#x0005b;31&#x0005d;</xref>. Moreover, in a model of ischemia and reperfusion injury, meprin was reported to be redistributed from the apical brush-border membrane to the basolateral side and the cytosol of tubular epithelial cells resulting in degradation of ECM and damage to adjacent peritubular structures <xref ref-type="bibr" rid="pone.0002278-Walker1">&#x0005b;21&#x0005d;</xref>. Recently, it could be shown that this relocalization occurs also in a mouse model of acute kidney injury using cisplatin, suggesting that common mechanisms for meprin redistribution are involved in toxic and ischemic renal injury <xref ref-type="bibr" rid="pone.0002278-Herzog2">&#x0005b;32&#x0005d;</xref>. Furthermore, meprin was found to be directly cytotoxic to cultured tubular epithelial cells and its inhibition by actinonin and by the metal chelator 1,10-phenanthroline resulted in a protective effect on cell integrity during ischemia-reperfusion injury in rats <xref ref-type="bibr" rid="pone.0002278-Carmago1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Kieran1">&#x0005b;33&#x0005d;</xref>.</p><p>Multiple studies have also revealed that meprin expression is down-regulated in models of renal injury leading to acute renal failure. For example, renal damage associated with hydronephrosis (unilateral urethral obstruction) occurred with an early and progressive decline in rat meprin subunits on both mRNA and protein levels <xref ref-type="bibr" rid="pone.0002278-Ricardo1">&#x0005b;34&#x0005d;</xref>. In addition, microarray analysis demonstrated marked declines in mouse meprin&#x003b2; expression in acute renal ischemic reperfusion injury and in adriamycin-induced nephropathy <xref ref-type="bibr" rid="pone.0002278-Kieran1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Sadlier1">&#x0005b;35&#x0005d;</xref>.</p><p>In a previous study using a rat model of chronic renal allograft rejection, we observed a concomitant down-regulation of meprin&#x003b2; and MMP-9 <xref ref-type="bibr" rid="pone.0002278-Berthier1">&#x0005b;36&#x0005d;</xref>. MMP-9 has been shown to be secreted by both mesangial cells and glomerular epithelial cells (podocytes) <xref ref-type="bibr" rid="pone.0002278-Martin1">&#x0005b;37&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Asanuma1">&#x0005b;39&#x0005d;</xref>. We therefore decided to check for meprin&#x003b2; expression in glomeruli and then to further assess meprin regulation in models of glomerular disease. For this purpose, we focused on meprin&#x003b2; expression in healthy rat kidney and in two models of rat glomerular disease: passive Heymann nephritis (PHN), a rat model of human membranous nephropathy, and anti-Thy 1.1 mesangial proliferative nephritis <xref ref-type="bibr" rid="pone.0002278-Lovett1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Marti2">&#x0005b;40&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Salant1">&#x0005b;42&#x0005d;</xref>. We demonstrate that a relocalization of the protease occurs following the induction of glomerular disease, an effect that may contribute to the pathogenesis of rat glomerulonephritis. Moreover, we demonstrate that meprin may represents a potential auto-antigen in PHN.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Meprin&#x003b2; expression in podocytes of rat glomeruli</title><p>To assess meprin&#x003b2; expression in healthy kidney paraffin-embedded kidney sections from Wistar rats were analyzed by immunostaining (<xref ref-type="fig" rid="pone-0002278-g001">Fig. 1</xref>). As expected, we observed strong apical staining of proximal tubular cells (PT) using a specific anti-meprin&#x003b2; antibody (<xref ref-type="fig" rid="pone-0002278-g001">Fig. 1A, 1E</xref>). In addition, glomeruli (G) also displayed positive meprin&#x003b2; staining (<xref ref-type="fig" rid="pone-0002278-g001">Fig. 1B, 1E</xref>). No signal was observed when the primary meprin&#x003b2; antibody was replaced by normal rabbit serum (<xref ref-type="fig" rid="pone-0002278-g001">Fig. 1C, 1F</xref>), or following pre-incubation with a five-fold excess of recombinant human meprin&#x003b2; (<xref ref-type="fig" rid="pone-0002278-g001">Fig. 1D</xref>). No effect on signal intensity was seen when the antibody was pre-incubated with bovine serum albumin (data not shown). We confirmed these data using Fisher and Lewis rats (supplementary <xref ref-type="supplementary-material" rid="pone.0002278.s001">Figure S1</xref>).</p><fig id="pone-0002278-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002278.g001</object-id><label>Figure 1</label><caption><title>Meprin&#x003b2; expression in Wistar rat kidneys.</title><p>Immunostaining of paraffin embedded kidney tissues from Wistar rats: (A) positive immunofluorescence staining of proximal tubules and (B) of glomeruli using a specific meprin&#x003b2; antibody. Control immunofluorescence staining: (C) replacement of the primary antibody with normal rabbit serum. (D) Competitive inhibition of meprin&#x003b2; by pre-incubation with an excess of recombinant meprin&#x003b2; (r-meprin&#x003b2;). (E) Positive immunohistochemical staining of glomeruli using a specific C-terminal meprin&#x003b2; antibody. Control immunohistochemical staining: (F) replacement of the primary antibody with normal rabbit serum. G: glomeruli, PT: proximal tubuli. Similar results were obtained using a different antibody directed against the N-terminal domain of meprin&#x003b2;.</p></caption><graphic xlink:href="pone.0002278.g001"/></fig><p>To further investigate the localization of meprin&#x003b2; in glomeruli, we double-stained the Wistar kidney sections with anti-meprin&#x003b2; antibodies and anti-synaptopodin or anti-Thy 1.1 antibodies (<xref ref-type="fig" rid="pone-0002278-g002">Fig. 2</xref>). Synaptopodin is abundantly expressed in the foot processes of podocytes whereas Thy 1.1 is localized on the surface of glomerular mesangial cells. The staining pattern of meprin&#x003b2; revealed co-localization with synaptopodin (<xref ref-type="fig" rid="pone-0002278-g002">Fig. 2A&#x02013;C</xref>), but not with Thy 1.1 (<xref ref-type="fig" rid="pone-0002278-g002">Fig. 2D&#x02013;F</xref>). Both meprin&#x003b2; and synaptopodin displayed a linear staining pattern drawing the contour of the intra-glomerular capillaries. These findings clearly demonstrate the expression of meprin&#x003b2; protein in podocytes of rat glomeruli.</p><fig id="pone-0002278-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002278.g002</object-id><label>Figure 2</label><caption><title>Double immunofluorescence staining of kidney sections from Wistar rats.</title><p>Immunofluorescence staining of glomeruli: (A) anti-meprin&#x003b2; antibody, (B) anti-synaptopodin antibody, (C) merged image meprin/synaptopodin, (D) anti-meprin&#x003b2; antibody, (E) anti-Thy 1.1 antibody, (F) merged image meprin/Thy 1.1. Nuclei are marked by staining with 4,6-diamidino-2-phenylindole (DAPI).</p></caption><graphic xlink:href="pone.0002278.g002"/></fig></sec><sec id="s2b"><title>mRNA expression of meprin&#x003b2; in glomeruli</title><p>Next, we analyzed the mRNA expression by real-time quantitative RT-PCR (RQ-PCR) on laser-capture microdissected glomeruli from Wistar rats (<xref ref-type="fig" rid="pone-0002278-g003">Fig. 3</xref>). Importantly, the tissue surrounding the captured glomeruli remained intact following microdissection (<xref ref-type="fig" rid="pone-0002278-g003">Fig. 3A, 3B</xref>). RQ-PCR analyses using 18S RNA as a house-keeping gene confirmed high meprin&#x003b2; mRNA expression in glomeruli. The signal of meprin&#x003b2; mRNA derived from the 200 collected glomeruli was 467-fold higher when compared to the level of the respective total kidney homogenate (arbitrarily set as 1.0-fold) (<xref ref-type="fig" rid="pone-0002278-g003">Fig. 3C</xref>), explained by the fact that all glomeruli contribute to meprin expression, while tubular meprin&#x003b2; is confined to some proximal tubules of the cortico-medullary section and is therefore diluted in a whole kidney homogenate. The meprin&#x003b2; mRNA results support the immunostaining data described above.</p><fig id="pone-0002278-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002278.g003</object-id><label>Figure 3</label><caption><title>Relative meprin&#x003b2; mRNA levels of laser-capture microdissected (LCM) glomeruli from Wistar rats.</title><p>Two hundred glomeruli were selected for microdissection with a laser. Kidney cortex (A) before and (B) following LCM treatment. The tissue surrounding the captured glomeruli remains intact after microdissection. The presence of meprin&#x003b2; was confirmed in the microdissected glomeruli by real-time quantitative PCR (C), and compared with the expression in the total homogenized kidney. mRNA levels were normalized with 18S as housekeeping gene.</p></caption><graphic xlink:href="pone.0002278.g003"/></fig></sec><sec id="s2c"><title>Meprin&#x003b2; in experimental PHN</title><p>PHN is a rat model of human membranous nephropathy associated with altered podocyte slit diaphragm integrity, sub-epithelial immune deposits and expansion of glomerular basal membranes <xref ref-type="bibr" rid="pone.0002278-Kerjaschki1">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Kerjaschki2">&#x0005b;44&#x0005d;</xref>. Analysis of kidney sections from control rats after injection of normal sheep globulin showed a linear staining pattern for meprin&#x003b2;. This changed to a granular staining following injection of anti-Fx1A antiserum to induce PHN (<xref ref-type="fig" rid="pone-0002278-g004">Fig. 4A&#x02013;C</xref>). At day 3, glomerular capillaries displayed a significant and well outlined meprin&#x003b2; and synaptopodin staining, whereas at day 6, the staining intensity became granular and clustered and the overall picture was less intense in signal strength (<xref ref-type="fig" rid="pone-0002278-g004">Fig. 4B&#x02013;F</xref> and <xref ref-type="fig" rid="pone-0002278-g004">Fig. 4</xref> compare J and K to L), with the granular pattern being more pronounced for synaptopodin (<xref ref-type="fig" rid="pone-0002278-g004">Fig. 4G, 4H</xref>), probably as a result of a deterioration of podocyte integrity (<xref ref-type="fig" rid="pone-0002278-g004">Fig. 4I</xref>).</p><fig id="pone-0002278-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002278.g004</object-id><label>Figure 4</label><caption><title>Meprin&#x003b2; expression in rat glomeruli after induction of Passive Heyman nephritis (PHN).</title><p>Immunofluorescence staining (A&#x02013;C) of meprin&#x003b2; and (D&#x02013;F) synaptopodin in kidney sections from Sprague-Dawley rats. (G&#x02013;I) Merged images of meprin/synaptopodin. (J&#x02013;L) Immunohistochemical staining of meprin&#x003b2; in glomeruli and in proximal tubules. Staining (A, D, G and J) in control rats, (B, E, H and K) in rats at day 3 and (C, F, I and L) in rats at day 6 after induction of PHN. A change in distribution of the meprin&#x003b2; in PHN kidneys from a linear to a granular appearance was observed concomitantly associated with an overall reduction in signal intensity. The distribution of meprin&#x003b2; and synaptopodin in glomeruli appeared increasingly divergent following progression of PHN.</p></caption><graphic xlink:href="pone.0002278.g004"/></fig></sec><sec id="s2d"><title>Detection of meprin&#x003b2; by anti-Fx1a antisera</title><p>Since the introduction of PHN as a model for auto-immune glomerulonephritis <xref ref-type="bibr" rid="pone.0002278-Heymann1">&#x0005b;45&#x0005d;</xref>, a substantial effort was made to identify responsible antigens. It has been recognized that biologically relevant antigens must be present in the brush borders of the proximal kidney tubules as well as in podocyte membranes. PHN is induced by the administration of sheep or rabbit anti-Fx1A antisera generated against the brush border membrane fractions of rat proximal kidney tubules. Meprin&#x003b2; is abundantly expressed in these membranes but, as shown above, also in glomeruli, the main target for the antibodies. Moreover, the staining pattern we observed for meprin&#x003b2; resembled the one obtained by immunostaining using anti-Fx1A <xref ref-type="bibr" rid="pone.0002278-Kerjaschki3">&#x0005b;46&#x0005d;</xref>. Hence, we checked if meprin&#x003b2; was detected by the anti-Fx1A antiserum using Western blot analysis. In kidney homogenate from Wistar rats we detected a band of 110-kDa corresponding to the molecular size of meprin&#x003b2; (<xref ref-type="fig" rid="pone-0002278-g005">Fig. 5A</xref>, lane 1). The same band was observed when the blot was stripped and re-probed with a specific anti-meprin&#x003b2; antibody to show the specificity of the detection by anti-Fx1A (<xref ref-type="fig" rid="pone-0002278-g005">Fig. 5A</xref>, lane 3). In contrast, no band was detected when the membrane was blotted with normal serum as a negative control (<xref ref-type="fig" rid="pone-0002278-g005">Fig. 5A</xref>, lane 2). A 110-kDa band corresponding to meprin&#x003b2; was also obtained after immunoprecipitation using anti-Fx1A antiserum, followed by Western blot analysis with a specific anti-meprin&#x003b2; antibody (<xref ref-type="fig" rid="pone-0002278-g005">Fig. 5B</xref>, lane 1). No band appeared when the kidney homogenate was immunoprecipitated with normal serum as a negative control (<xref ref-type="fig" rid="pone-0002278-g005">Fig. 5B</xref>, lane 2). In addition, we stably transfected Madin-Darby canine kidney (MDCK) cells with human meprin&#x003b2;. Wild-type and meprin&#x003b2; transfected MDCK cells were then subjected to immunoprecipitation using anti-Fx1A antiserum, followed by Western blot analysis with anti-meprin&#x003b2; antibody. We obtained a 110-kDa band in lysates of meprin&#x003b2;-transfected MDCK cells whereas in wild-type MDCK cells this band was absent (<xref ref-type="fig" rid="pone-0002278-g005">Fig. 5B</xref>, line 3 and 5B, line 4). These findings clearly demonstrate that the anti-Fx1A antiserum, in addition to other brush border membrane proteins, detects meprin&#x003b2;. Meprin&#x003b2; could therefore be recognized at the podocyte membrane by the anti-Fx1A antiserum and thus contribute to the pathology of PHN as another auto-antigen.</p><fig id="pone-0002278-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002278.g005</object-id><label>Figure 5</label><caption><title>Meprin&#x003b2; is recognized by anti-Fx1A antiserum.</title><p>(A) Homogenized kidneys from Wistar rats were prepared and analyzed by Western blotting using sheep anti-Fx1A antiserum (lane 1), normal serum (NS) (lane 2) and meprin&#x003b2; specific antibody (lane 3). A 110-kDa band was detected using the anti-Fx1A antiserum (lane 1) which corresponds to the meprin&#x003b2; specific band (lane 3). No specific signal was detectable when normal serum was used as negative control (lane 2). (B) Anti-Fx1A antiserum was used to immunoprecipitate the proteins from homogenized rat kidneys or from the cell lysates of wild-type and human meprin&#x003b2;-transfected MDCK cells. Normal sheep serum was used instead of anti-Fx1A antiserum as negative control. Immunoprecipitates were analyzed by Western blots using a specific meprin&#x003b2; antibody. A 110-kDa fragment corresponding to meprin&#x003b2; was found exclusively in the rat kidney (lane 1) and meprin&#x003b2;-transfected MDCK cell lysates (lane 3) when immunoprecipitation was performed with anti-Fx1A antisera whereas no band was visualized with normal serum (lane 2). (C) Immuno-gold labeling shows meprin&#x003b2; localization in podocyte major processes (MP) and foot processes (FP), as indicated by arrows. Meprin&#x003b2; is located in the membrane of the podocyte. GBM: glomerular basal membrane. CL: capillary lumen.</p></caption><graphic xlink:href="pone.0002278.g005"/></fig><p>To further strengthen this hypothesis, we analyzed the subcellular localization of meprin&#x003b2; by immuno-gold labelling of ultra-thin sections of kidney cortex from adult Wistar rats using the specific anti-meprin&#x003b2; antibody (<xref ref-type="fig" rid="pone-0002278-g005">Fig. 5C</xref>). Gold particles were found mostly at the membrane of podocyte foot processes and main processes, facing the urinary space and, to less extent, at the slit diaphragm. Meprin&#x003b2;, an ectoenzyme, is thus accessible to circulating antibodies in rat glomeruli and this could lead to the formation and deposition of immuno-complexes and to the development of glomerulonephritis.</p></sec><sec id="s2e"><title>Meprin&#x003b2; in experimental anti-Thy 1.1 nephritis</title><p>Anti-Thy 1.1 nephritis is characterized by an initial phase of complement-dependent mesangiolysis lasting for approximately 2 days, followed by a marked proliferative response of the residual mesangial cells associated with the accumulation of ECM <xref ref-type="bibr" rid="pone.0002278-Floege2">&#x0005b;47&#x0005d;</xref>. We observed in preliminary experiments that the latter two features were reached at day 11 <xref ref-type="bibr" rid="pone.0002278-SteinmannNiggli1">&#x0005b;48&#x0005d;</xref>. Therefore, this time point was chosen for nephrectomy and subsequent meprin&#x003b2; immunostaining (<xref ref-type="fig" rid="pone-0002278-g006">Fig. 6</xref>). We observed a dramatic decrease in meprin&#x003b2; expression in all glomeruli tested at day 11 after anti-Thy 1.1 injection (<xref ref-type="fig" rid="pone-0002278-g006">Fig. 6B</xref>). In contrast, in control rats injected with PBS we observed normal meprin&#x003b2; protein levels (<xref ref-type="fig" rid="pone-0002278-g006">Fig. 6A</xref>). This observation is in accordance with the alterations in glomerular structure featuring various glomerular diseases, particularly at the level of podocytes. Substantial damage to glomeruli was also reflected by a distorted synaptopodin staining, indicating loss of podocyte integrity (data not shown). These changes in protein levels occur along with the onset of proteinuria, having a maximum around day 2 and 3 after induction of disease. Moreover, we also noticed a different staining pattern in proximal tubules: in control rats, a strong signal was localized at the apical plasma membrane, whereas kidney sections of nephritic rats displayed a more diffuse staining throughout the tubular epithelial cells (<xref ref-type="fig" rid="pone-0002278-g006">Fig. 6D&#x02013;6F</xref>). These findings point to a differential and rapid relocalization of meprin&#x003b2; towards the basolateral side and the cytoplasm of proximal tubular cells during mesangioproliferative glomerulonephritis.</p><fig id="pone-0002278-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002278.g006</object-id><label>Figure 6</label><caption><title>Meprin&#x003b2; expression in experimental anti-Thy 1.1 nephritis.</title><p>Meprin&#x003b2; was detected by immunofluorescence and by immunohistochemistry in kidney sections (A, C and E) of healthy Wistar rats and (B, D and F) of Wistar rats at day 11 after induction of anti-Thy 1.1 nephritis. In nephritic rats, meprin&#x003b2; expression is decreased in the glomeruli. Moreover, meprin&#x003b2; expression is not only restricted to the brush border membrane of the tubules, but is also found diffusely spread within the tubular cells, as indicated by the arrow.</p></caption><graphic xlink:href="pone.0002278.g006"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>Meprin comprises approximately 5&#x00025; of the brush border membrane in rodent kidney, only second in abundance to actin <xref ref-type="bibr" rid="pone.0002278-Bond3">&#x0005b;49&#x0005d;</xref>. Hence it is considered to be the major protein of the microvillar membrane with activity for degrading extracellular matrix proteins <xref ref-type="bibr" rid="pone.0002278-Walker1">&#x0005b;21&#x0005d;</xref>. Numerous studies have demonstrated that renal meprin expression plays a key role in the severity and progression of renal injury, with meprin exacerbating the disease.</p><p>In our study we detected for the first time meprin&#x003b2; expression in the glomeruli of three different rat strains, a finding expanding our knowledge on meprin's previously described expression in the apical membrane of proximal tubular epithelial cells. Interestingly, a metalloendopeptidase with a molecular weight corresponding to that of meprin was previously found in rat glomeruli, but was not identified <xref ref-type="bibr" rid="pone.0002278-Le1">&#x0005b;50&#x0005d;</xref>. Using specific markers for glomerular cells and immuno-gold staining we identified the membrane of podocyte foot processes as the main site of glomerular expression of meprin&#x003b2;.</p><p>In two different rat models of glomerulonephritis we detected changes in the expression pattern of meprin&#x003b2;, both in the glomeruli as well as in the proximal tubules. In passive Heymann nephritis (PHN), the immunofluorescence signal for meprin&#x003b2; in glomeruli paralleled that of synaptopodin. An increasingly granular staining was observed indicative of the disruption in structural integrity of the podocyte foot processes. In addition, the intensity of meprin&#x003b2; staining was decreased both in the glomeruli and in the proximal tubules with disease progression. PHN is induced by the administration of antibodies generated against a membrane fraction of rat renal proximal tubular cells (sheep or rabbit anti-Fx1A antibodies), which results in the formation and deposition of sub-epithelial immune complexes at the glomerular basement membrane (GBM) <xref ref-type="bibr" rid="pone.0002278-Kamata1">&#x0005b;51&#x0005d;</xref>. This leads to the disruption of the functional integrity of the GBM and the filtration barrier, which in turn results in proteinuria. Megalin, a multiligand endocytic receptor, localized in the microvillus membrane of proximal tubular epithelial cells, was previously identified as an antigen in these immune deposits <xref ref-type="bibr" rid="pone.0002278-Farquhar1">&#x0005b;52&#x0005d;</xref>. The observation of identical staining patterns with anti-meprin&#x003b2; and anti-rat Fx1A antibodies <xref ref-type="bibr" rid="pone.0002278-Kerjaschki3">&#x0005b;46&#x0005d;</xref>, the direct detection of meprin&#x003b2; by anti-Fx1A antibody in Western blots and in immunoprecipitation assays, and the subcellular localization of meprin&#x003b2; in the membrane of podocyte foot processes all suggest that meprin&#x003b2; may be involved in the pathogenesis of PHN by representing another auto-antigen. The decrease of meprin&#x003b2; immunostaining signal in glomeruli from rats with PHN may reflect the typical injury of podocytes in this disease or may reflect a reduced binding affinity of the staining antibody to the meprin&#x003b2;-immunocomplexes.</p><p>Physiologically, the integrity and the structure of the glomerular basement membrane (GBM) is maintained by the podocytes in a continuous replacement and recycling effected by proteases <xref ref-type="bibr" rid="pone.0002278-Harvey1">&#x0005b;53&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Abbate1">&#x0005b;56&#x0005d;</xref>. Meprin, expressed by podocytes, may act as such a processing entity in breaking down GBM components, prior to being substituted by new matrix proteins. A plethora of ECM components are processed by meprin <italic>in vitro</italic>, such as laminin, collagen IV, nidogen and fibronectin <xref ref-type="bibr" rid="pone.0002278-Kruse1">&#x0005b;19&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002278-Walker1">&#x0005b;21&#x0005d;</xref>. Damage to the podocytes, either directly in PHN or indirectly through mesangial injury in Thy 1.1 nephritis, may then interfere with the normal turnover function of meprin and may thus disturb the steady-state processing of GBM components and hence enhance progression of the disease.</p><p>Thy 1.1 nephritis is a reversible glomerular disease that affects mesangial cells. We observed a loss of meprin&#x003b2; signal in rat podocytes at day 11 following induction of the disease. We postulate that the damage occurring in the mesangial compartment may also lead to changes in podocytes in Thy 1.1 nephritis. In addition, we observed a marked alteration in meprin&#x003b2; staining of proximal tubular cells despite the fact that Thy 1.1 nephritis is a glomerular disease: the immunostaining revealed a shift from a linear staining confined to the apical brush border membrane in the corticomedullary junction towards a diffuse cytoplasmatic staining involving the tubular basement membrane. These findings are reminiscent of meprin&#x003b2; relocalizations reported in tubular nephritis such as in hypoxia/reperfusion injury <xref ref-type="bibr" rid="pone.0002278-Carmago1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Walker1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Trachtman1">&#x0005b;31&#x0005d;</xref> or in an acute kidney injury model of cisplatin nephrotoxicity <xref ref-type="bibr" rid="pone.0002278-Herzog2">&#x0005b;32&#x0005d;</xref>. These data provide evidence that high levels of meprin are present in locations other than the apical membrane exposing the protease to a distinct set of substrates not normally available to meprin&#x003b2;. These include proteins of the basement membranes and cell-cell adhesion complexes. It has been shown that mice with low renal meprin expression levels had less severe forms of structural injury when compared to mice with higher meprin levels <xref ref-type="bibr" rid="pone.0002278-Trachtman1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Craig1">&#x0005b;57&#x0005d;</xref>. Therefore, expression of meprin in epithelial cells of proximal tubules appears to be detrimental in an already stressed kidney and thus worsens the disease course.</p><p>This report is to our best knowledge the first to show expression of the metalloendopeptidase meprin&#x003b2; in rat glomeruli. Moreover, our results suggest that localization, balance and regulation of meprin&#x003b2; may constitute features in kidney disease progression. In order to investigate whether meprin&#x003b2; also has a direct, causal role in the pathogenesis of glomerulonephritis such as PHN, further experiments using animal models are needed. Moreover, it will be interesting to correlate our results with studies in human glomerulonephritis to assess a role of meprin&#x003b2; as a possible auto-antigen in membranous nephropathy.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Animal tissues</title><p>Paraffin-embedded kidney tissues from Fisher and Lewis rat strains were kindly provided by collaborators in Leiden, The Netherlands. Approval for the studies was obtained from the local animal studies commission.</p><p>The rats were sacrificed by intra-peritoneal injection of 1 ml of pentobarbital. After nephrectomy the kidneys were either snap frozen in liquid nitrogen and stored at -80&#x000b0;C, or fixed for 24 hours in 5&#x00025; buffered formalin, de-hydrated and embedded in paraffin.</p></sec><sec id="s4b"><title>Induction of disease</title><p>Anti-Thy 1.1 nephritis was induced at day 0 in Wistar rats (150 g body weight) by an intravenous injection of anti-Thy1.1 IgG (OX-7; 1 mg/kg body weight in 500 &#x000b5;l PBS) as previously described <xref ref-type="bibr" rid="pone.0002278-SteinmannNiggli1">&#x0005b;48&#x0005d;</xref>. Kidneys were harvested 11 days after injection, fixed in formalin and embedded in paraffin.</p><p>PHN was induced in male Sprague-Dawley rats (weighing 180 g to 200 g) by intra-peritoneal injection (5 ml/kg body weight) of sheep anti-Fx1A antibody prepared as described previously <xref ref-type="bibr" rid="pone.0002278-Shankland1">&#x0005b;58&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002278-Baker1">&#x0005b;59&#x0005d;</xref>. Rats were sacrificed 3 or 6 days after induction of nephritis.</p></sec><sec id="s4c"><title>Immunohistology</title><p>Immunohistochemistry of meprin&#x003b2; on rat kidney section was performed as described previously <xref ref-type="bibr" rid="pone.0002278-Berthier1">&#x0005b;36&#x0005d;</xref>. Replacement of the primary antibody with normal rabbit serum served as a control for the staining specificity (DAKO Diagnostics, Zug, Switzerland).</p></sec><sec id="s4d"><title>Immunofluorescence</title><p>The paraffin-embedded kidney sections were de-waxed, re-hydrated and pre-treated by heating in a microwave oven in 10 mM citrate buffer, pH 5.65. Thereafter, sections were washed with PBS and incubated in 5&#x00025; bovine serum albumin blocking solution, before further incubation with the primary antibody for 1 hour at room temperature. Sections were then incubated with fluorescence labelled secondary antibody for 45 min at room temperature in the dark, 4,6-diamidino-2-phenylindole (DAPI) stained for 2 min, mounted in Dako Cytomation Fluorescence-Mounting Medium and sealed with a cover slip. To prove specificity of the antisera, we either re-placed the primary antibodies with normal rabbit serum (DAKO Diagnostic) or we pre-incubated the primary antibody with recombinant meprin&#x003b2; (competitive inhibition) <xref ref-type="bibr" rid="pone.0002278-BeckerPauly1">&#x0005b;60&#x0005d;</xref>. For double labelling, we applied a second primary antibody for 1 hour. We used the following antibodies: primary rabbit polyclonal anti-meprin&#x003b2;, targeting amino acids 468&#x02013;612 of meprin&#x003b2;, as previously described <xref ref-type="bibr" rid="pone.0002278-Lottaz1">&#x0005b;61&#x0005d;</xref>, primary mouse monoclonal anti-synaptopodin (Progen, Heidelberg, Germany), primary monoclonal mouse anti-Thy 1.1 (Oxford Biotechology, UK), secondary goat anti-rabbit and goat anti-mouse (Dako Cytomation, Denmark), diluted 1:500, 1:4, 1:20, 1:1000 and 1:400 respectively.</p></sec><sec id="s4e"><title>Immunoelectron microscopy</title><p>Isolated rat kidneys were fixed in 0.1&#x00025; glutaraldehyde and 3&#x00025; paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 3 hours at room temperature. Fixed tissue was dehydrated to 96&#x00025; ethanol, embedded in LR White hard (Science Services, Munich, Germany), and polymerized at 4&#x000b0;C under ultraviolet (UV) light for 48&#x02013;60 hours. Ultrathin sections (50 nm) were cut on a Leica Ultracut S and were collected on Formvar-coated nickel grids. Sections were first etched with saturated sodium periodate (Sigma) at room temperature for 2 min. The grids were pre-incubated with 0.1&#x00025; Tween 20 in phosphate-buffered saline (PBS), then blocked with 50 mM NH<sub>4</sub>Cl in PBS and in blocking solution (0.5&#x00025; fish gelatine (Sigma) plus 0.1&#x00025; ovalbumin (Sigma) in PBS). Sections were incubated with primary antibodies against meprin&#x003b2; diluted in blocking solution at 4&#x000b0;C for 60 hours, washed in PBS and twice in a mixture of 0.1&#x00025; ovalbumin, 0.5&#x00025; cold-water fish gelatin, 0.01&#x00025; Tween 20, 0.5 M NaCl in 10 mM phosphate buffer, pH 7.3 (IgG-gold buffer). The sections were incubated for 2 hours with goat anti-rabbit Fab conjugated to nanogold&#x02122; (1.4-nm gold particles; Nanoprobes, Stony Brook, NY), diluted in IgG-gold buffer. Washed sections were postfixed in 1&#x00025; glutaraldehyde for 5 min and air-dried. The nanogold&#x02122; labeling was silver-enhanced for 25 min at room temperature as described <xref ref-type="bibr" rid="pone.0002278-Danscher1">&#x0005b;62&#x0005d;</xref>. The grids were then washed in distilled water and stained with 2&#x00025; ethanolic uranyl acetate for 10 min and with lead citrate for 2 min before examination in a FEI Tecnai 12 TEM <xref ref-type="bibr" rid="pone.0002278-Sato1">&#x0005b;63&#x0005d;</xref>.</p></sec><sec id="s4f"><title>Laser-capture microdissection (LCM) and reverse transcription</title><p>Kidneys of Wistar rats were embedded individually in polyethylene glycol freezing media (Tissue-Tek OCT Compound, Sakura Finetek, Torrance, CA, USA), placed at -20&#x000b0;C for 1 hour and then stored at &#x02212;80&#x000b0;C. Tissues were sectioned and mounted on PALM PEN-covered membrane slides (PALM AG, Bernried, Germany). LCM was performed immediately after sectioning. Sections were stained with hematoxylin for 20 s using the HistoGene Staining Solution (Arcturus HistoGene, LCM Frozen Section Staining Kit, CA, USA) and dehydrated in graded solutions of ethanol for 30 s each. Once air-dried, 200 glomeruli were microdissected and catapulted into PALM adhesive caps tubes using the laser microdissector pressure catapulting device (PALM AG, Bernried, Germany). Cells were lysed in RNA extraction buffer and total RNA was extracted using the PicoPure RNA Isolation Kit (Arcturus). Total RNA was reverse-transcribed according to the manufacturer's instructions (Promega, Catalys AG, Wallisellen, Switzerland).</p></sec><sec id="s4g"><title>Real-time quantitative RT-PCR (RQ-PCR)</title><p>cDNA was used as a template for RQ-PCR analysis with the Applied Biosystems 7500 PCR System according to the manufacturer's protocol in a reaction volume of 20 &#x000b5;l containing 1x TaqMan Universal PCR Master Mix and 1x TaqMan gene expression assay (Applied Biosystems Rotkreuz, Switzerland). All the target genes were measured in duplicates. To detect genomic DNA contamination, all analyses were also carried out without reverse transcriptase and without template as negative controls. 18S RNA expression levels served as a housekeeping gene to normalize expression between different samples and to monitor assay reproducibility. Relative quantification of all targets was calculated by the comparative cycle threshold method outlined by the manufacturer (User Bulletin No. 2; Applied Biosystems).</p></sec><sec id="s4h"><title>Immunoblot and immunoprecipitation assay</title><p>Homogenized kidney from Wistar rats or cell pellets of the stably transfected MDCK&#x003b2; and WT <xref ref-type="bibr" rid="pone.0002278-Eldering1">&#x0005b;64&#x0005d;</xref> were lysed in buffer A (25 mM Tris/HCl pH 8, 50 mM NaCl) containing 1&#x00025; deoxycholic acid and 1&#x00025; Nonidet P-40 in the presence of protease inhibitors for 30 min on ice. Protein extracts were then denatured by boiling 5 min with SDS 0.5&#x00025; followed by electrophoresis on 7.5 or 10&#x00025; SDS-polyacrylamide gels and transfer to polyvinylidene difluoride membranes (Hybond&#x02013;P PVDF, Amersham Biosciences, Uppsala, Sweden). The membranes were saturated with 5&#x00025; dry milk and 0.1&#x00025; Tween-20 in Tris-buffered saline for 2 hours, incubated overnight with the Fx1A antibody (1:1000) or the specific meprin&#x003b2; antibody (1:2000) and then incubated with horseradish peroxidase-conjugated anti-sheep IgG (1:5000) for 1.5 hours at room temperature. Immunocomplexes were visualized using the ECL Plus Western blotting kit (Amersham Biosciences) and X-ray films.</p><p>For immunoprecipitation, denatured protein extracts were incubated with 50 &#x000b5;l of protein G-Sepharose beads conjugated with the Fx1A antibody for 30 min at 4&#x000b0;C. Immune complexes were pelleted by microcentrifugation at 15000 g for 5 min at 4&#x000b0;C and washed 4 times with 0.5&#x00025; Nonidet P-40, 0.05&#x00025; deoxycholic acid and 0.05&#x00025; SDS in NaCl/P<sub>i</sub>. The immunoprecipitate was then subjected to immunoblotting using anti-meprin&#x003b2; antibodies as described above.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0002278.s001"><label>Figure S1</label><caption><p>Meprin&#x003b2; expression in Fisher and Lewis rat kidneys. Immunostaining of paraffin-embedded kidney sections (A and C) from Fisher and (B and D) Lewis rats. Positive staining of glomeruli and proximal tubules (A and B) in immunohistochemical sections and (C, D) in immunofluorescence sections using the C-terminal anti-meprin&#x003b2; antibody.</p><p>(2.15 MB DOC)</p></caption><media xlink:href="pone.0002278.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors thank Dr. Uwe Wolfrum, Dr. Andreas Giessl, Elisabeth Sehn and Gabi Stern-Schneider for excellent assistance in electron microscopy.</p></ack><ref-list><title>References</title><ref id="pone.0002278-Johnson1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Lombardi</surname><given-names>D</given-names></name><name><surname>Eng</surname><given-names>E</given-names></name><name><surname>Gordon</surname><given-names>K</given-names></name><name><surname>Alpers</surname><given-names>CE</given-names></name><etal/></person-group><year>1995</year><article-title>Modulation of experimental mesangial proliferative nephritis by interferon-gamma.</article-title><source>Kidney Int</source><volume>47</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">7731171</pub-id></citation></ref><ref id="pone.0002278-Akagi1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akagi</surname><given-names>Y</given-names></name><name><surname>Isaka</surname><given-names>Y</given-names></name><name><surname>Arai</surname><given-names>M</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name><name><surname>Takenaka</surname><given-names>M</given-names></name><etal/></person-group><year>1996</year><article-title>Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis.</article-title><source>Kidney Int</source><volume>50</volume><fpage>148</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">8807583</pub-id></citation></ref><ref id="pone.0002278-Lovett1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lovett</surname><given-names>DH</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Marti</surname><given-names>HP</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><etal/></person-group><year>1992</year><article-title>Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.</article-title><source>Am J Pathol</source><volume>141</volume><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">1321565</pub-id></citation></ref><ref id="pone.0002278-Turck1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turck</surname><given-names>J</given-names></name><name><surname>Pollock</surname><given-names>AS</given-names></name><name><surname>Lee</surname><given-names>LK</given-names></name><name><surname>Marti</surname><given-names>HP</given-names></name><name><surname>Lovett</surname><given-names>DH</given-names></name></person-group><year>1996</year><article-title>Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation.</article-title><source>J Biol Chem</source><volume>271</volume><fpage>15074</fpage><lpage>15083</lpage><pub-id pub-id-type="pmid">8663054</pub-id></citation></ref><ref id="pone.0002278-Marti1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marti</surname><given-names>HP</given-names></name><name><surname>McNeil</surname><given-names>L</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Lovett</surname><given-names>DH</given-names></name></person-group><year>1992</year><article-title>Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1.</article-title><source>Biochem J</source><volume>285 ( Pt 3)</volume><fpage>899</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">1497627</pub-id></citation></ref><ref id="pone.0002278-Killar1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Killar</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>J</given-names></name><name><surname>Black</surname><given-names>R</given-names></name><name><surname>Peschon</surname><given-names>J</given-names></name></person-group><year>1999</year><article-title>Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).</article-title><source>Ann N Y Acad Sci</source><volume>878</volume><fpage>442</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">10415747</pub-id></citation></ref><ref id="pone.0002278-Duffy1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>MJ</given-names></name><name><surname>Lynn</surname><given-names>DJ</given-names></name><name><surname>Lloyd</surname><given-names>AT</given-names></name><name><surname>O'Shea</surname><given-names>CM</given-names></name></person-group><year>2003</year><article-title>The ADAMs family of proteins: from basic studies to potential clinical applications.</article-title><source>Thromb Haemost</source><volume>89</volume><fpage>622</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">12669115</pub-id></citation></ref><ref id="pone.0002278-Rao1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>VH</given-names></name><name><surname>Meehan</surname><given-names>DT</given-names></name><name><surname>Delimont</surname><given-names>D</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Wada</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome.</article-title><source>Am J Pathol</source><volume>169</volume><fpage>32</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">16816359</pub-id></citation></ref><ref id="pone.0002278-Zeisberg1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeisberg</surname><given-names>M</given-names></name><name><surname>Khurana</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>VH</given-names></name><name><surname>Cosgrove</surname><given-names>D</given-names></name><name><surname>Rougier</surname><given-names>JP</given-names></name><etal/></person-group><year>2006</year><article-title>Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.</article-title><source>PLoS Med</source><volume>3</volume><fpage>e100</fpage><pub-id pub-id-type="pmid">16509766</pub-id></citation></ref><ref id="pone.0002278-Carmago1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carmago</surname><given-names>S</given-names></name><name><surname>Shah</surname><given-names>SV</given-names></name><name><surname>Walker</surname><given-names>PD</given-names></name></person-group><year>2002</year><article-title>Meprin, a brush-border enzyme, plays an important role in hypoxic/ischemic acute renal tubular injury in rats.</article-title><source>Kidney Int</source><volume>61</volume><fpage>959</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">11849450</pub-id></citation></ref><ref id="pone.0002278-Norman1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname><given-names>LP</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Saunders</surname><given-names>TL</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>2003</year><article-title>Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles.</article-title><source>Mol Cell Biol</source><volume>23</volume><fpage>1221</fpage><lpage>1230</lpage><pub-id pub-id-type="pmid">12556482</pub-id></citation></ref><ref id="pone.0002278-Sterchi1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sterchi</surname><given-names>EE</given-names></name><name><surname>Green</surname><given-names>JR</given-names></name><name><surname>Lentze</surname><given-names>MJ</given-names></name></person-group><year>1982</year><article-title>Non-pancreatic hydrolysis of N-benzoyl-l-tyrosyl-p-aminobenzoic acid (PABA-peptide) in the human small intestine.</article-title><source>Clin Sci (Lond)</source><volume>62</volume><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">7042181</pub-id></citation></ref><ref id="pone.0002278-Sterchi2"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sterchi</surname><given-names>EE</given-names></name><name><surname>Green</surname><given-names>JR</given-names></name><name><surname>Lentze</surname><given-names>MJ</given-names></name></person-group><year>1983</year><article-title>Nonpancreatic hydrolysis of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA peptide) in the rat small intestine.</article-title><source>J Pediatr Gastroenterol Nutr</source><volume>2</volume><fpage>539</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">6352892</pub-id></citation></ref><ref id="pone.0002278-Sterchi3"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sterchi</surname><given-names>EE</given-names></name><name><surname>Naim</surname><given-names>HY</given-names></name><name><surname>Lentze</surname><given-names>MJ</given-names></name></person-group><year>1988</year><article-title>Biosynthesis of N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase: disulfide-linked dimers are formed at the site of synthesis in the rough endoplasmic reticulum.</article-title><source>Arch Biochem Biophys</source><volume>265</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">3261962</pub-id></citation></ref><ref id="pone.0002278-Sterchi4"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sterchi</surname><given-names>EE</given-names></name><name><surname>Naim</surname><given-names>HY</given-names></name><name><surname>Lentze</surname><given-names>MJ</given-names></name><name><surname>Hauri</surname><given-names>HP</given-names></name><name><surname>Fransen</surname><given-names>JA</given-names></name></person-group><year>1988</year><article-title>N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase: a metalloendopeptidase of the human intestinal microvillus membrane which degrades biologically active peptides.</article-title><source>Arch Biochem Biophys</source><volume>265</volume><fpage>105</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">3261961</pub-id></citation></ref><ref id="pone.0002278-Bertenshaw1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertenshaw</surname><given-names>GP</given-names></name><name><surname>Norcum</surname><given-names>MT</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>2003</year><article-title>Structure of homo- and hetero-oligomeric meprin metalloproteases. Dimers, tetramers, and high molecular mass multimers.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>2522</fpage><lpage>2532</lpage><pub-id pub-id-type="pmid">12399461</pub-id></citation></ref><ref id="pone.0002278-Becker1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Kruse</surname><given-names>MN</given-names></name><name><surname>Slotty</surname><given-names>KA</given-names></name><name><surname>Kohler</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>JR</given-names></name><etal/></person-group><year>2003</year><article-title>Differences in the activation mechanism between the alpha and beta subunits of human meprin.</article-title><source>Biol Chem</source><volume>384</volume><fpage>825</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">12817480</pub-id></citation></ref><ref id="pone.0002278-Villa1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>JP</given-names></name><name><surname>Bertenshaw</surname><given-names>GP</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>2003</year><article-title>Critical amino acids in the active site of meprin metalloproteinases for substrate and peptide bond specificity.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>42545</fpage><lpage>42550</lpage><pub-id pub-id-type="pmid">12888571</pub-id></citation></ref><ref id="pone.0002278-Kruse1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kruse</surname><given-names>MN</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Lottaz</surname><given-names>D</given-names></name><name><surname>Kohler</surname><given-names>D</given-names></name><name><surname>Yiallouros</surname><given-names>I</given-names></name><etal/></person-group><year>2004</year><article-title>Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.</article-title><source>Biochem J</source><volume>378</volume><fpage>383</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">14594449</pub-id></citation></ref><ref id="pone.0002278-Kohler1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohler</surname><given-names>D</given-names></name><name><surname>Kruse</surname><given-names>M</given-names></name><name><surname>Stocker</surname><given-names>W</given-names></name><name><surname>Sterchi</surname><given-names>EE</given-names></name></person-group><year>2000</year><article-title>Heterologously overexpressed, affinity-purified human meprin alpha is functionally active and cleaves components of the basement membrane in vitro.</article-title><source>FEBS Lett</source><volume>465</volume><fpage>2</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10620696</pub-id></citation></ref><ref id="pone.0002278-Walker1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>PD</given-names></name><name><surname>Kaushal</surname><given-names>GP</given-names></name><name><surname>Shah</surname><given-names>SV</given-names></name></person-group><year>1998</year><article-title>Meprin A, the major matrix degrading enzyme in renal tubules, produces a novel nidogen fragment in vitro and in vivo.</article-title><source>Kidney Int</source><volume>53</volume><fpage>1673</fpage><lpage>1680</lpage><pub-id pub-id-type="pmid">9607199</pub-id></citation></ref><ref id="pone.0002278-Bond1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>JS</given-names></name><name><surname>Beynon</surname><given-names>RJ</given-names></name></person-group><year>1995</year><article-title>The astacin family of metalloendopeptidases.</article-title><source>Protein Sci</source><volume>4</volume><fpage>1247</fpage><lpage>1261</lpage><pub-id pub-id-type="pmid">7670368</pub-id></citation></ref><ref id="pone.0002278-Bond2"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>JS</given-names></name><name><surname>Matters</surname><given-names>GL</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Dusheck</surname><given-names>RE</given-names></name></person-group><year>2005</year><article-title>Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer.</article-title><source>FEBS Lett</source><volume>579</volume><fpage>3317</fpage><lpage>3322</lpage><pub-id pub-id-type="pmid">15943977</pub-id></citation></ref><ref id="pone.0002278-Chestukhin1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chestukhin</surname><given-names>A</given-names></name><name><surname>Litovchick</surname><given-names>L</given-names></name><name><surname>Muradov</surname><given-names>K</given-names></name><name><surname>Batkin</surname><given-names>M</given-names></name><name><surname>Shaltiel</surname><given-names>S</given-names></name></person-group><year>1997</year><article-title>Unveiling the substrate specificity of meprin beta on the basis of the site in protein kinase A cleaved by the kinase splitting membranal proteinase.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>3153</fpage><lpage>3160</lpage><pub-id pub-id-type="pmid">9013548</pub-id></citation></ref><ref id="pone.0002278-Bertenshaw2"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertenshaw</surname><given-names>GP</given-names></name><name><surname>Turk</surname><given-names>BE</given-names></name><name><surname>Hubbard</surname><given-names>SJ</given-names></name><name><surname>Matters</surname><given-names>GL</given-names></name><name><surname>Bylander</surname><given-names>JE</given-names></name><etal/></person-group><year>2001</year><article-title>Marked differences between metalloproteases meprin A and B in substrate and peptide bond specificity.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>13248</fpage><lpage>13255</lpage><pub-id pub-id-type="pmid">11278902</pub-id></citation></ref><ref id="pone.0002278-Herzog1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herzog</surname><given-names>C</given-names></name><name><surname>Kaushal</surname><given-names>GP</given-names></name><name><surname>Haun</surname><given-names>RS</given-names></name></person-group><year>2005</year><article-title>Generation of biologically active interleukin-1beta by meprin B.</article-title><source>Cytokine</source><volume>31</volume><fpage>394</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">16095909</pub-id></citation></ref><ref id="pone.0002278-Choudry1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choudry</surname><given-names>Y</given-names></name><name><surname>Kenny</surname><given-names>AJ</given-names></name></person-group><year>1991</year><article-title>Hydrolysis of transforming growth factor-alpha by cell-surface peptidases in vitro.</article-title><source>Biochem J</source><volume>280 (Pt 1)</volume><fpage>57</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">1741757</pub-id></citation></ref><ref id="pone.0002278-Villa2"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>JP</given-names></name><name><surname>Bertenshaw</surname><given-names>GP</given-names></name><name><surname>Bylander</surname><given-names>JE</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>2003</year><article-title>Meprin proteolytic complexes at the cell surface and in extracellular spaces.</article-title><source>Biochem Soc Symp</source><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">14587282</pub-id></citation></ref><ref id="pone.0002278-Hengst1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hengst</surname><given-names>JA</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>2004</year><article-title>Transport of meprin subunits through the secretory pathway: role of the transmembrane and cytoplasmic domains and oligomerization.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>34856</fpage><lpage>34864</lpage><pub-id pub-id-type="pmid">15187079</pub-id></citation></ref><ref id="pone.0002278-Beynon1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beynon</surname><given-names>RJ</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>1983</year><article-title>Deficiency of a kidney metalloproteinase activity in inbred mouse strains.</article-title><source>Science</source><volume>219</volume><fpage>1351</fpage><lpage>1353</lpage><pub-id pub-id-type="pmid">6338590</pub-id></citation></ref><ref id="pone.0002278-Trachtman1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trachtman</surname><given-names>H</given-names></name><name><surname>Valderrama</surname><given-names>E</given-names></name><name><surname>Dietrich</surname><given-names>JM</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>1995</year><article-title>The role of meprin A in the pathogenesis of acute renal failure.</article-title><source>Biochem Biophys Res Commun</source><volume>208</volume><fpage>498</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">7695599</pub-id></citation></ref><ref id="pone.0002278-Herzog2"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herzog</surname><given-names>C</given-names></name><name><surname>Seth</surname><given-names>R</given-names></name><name><surname>Shah</surname><given-names>SV</given-names></name><name><surname>Kaushal</surname><given-names>GP</given-names></name></person-group><year>2007</year><article-title>Role of meprin A in renal tubular epithelial cell injury.</article-title><source>Kidney Int</source></citation></ref><ref id="pone.0002278-Kieran1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kieran</surname><given-names>NE</given-names></name><name><surname>Doran</surname><given-names>PP</given-names></name><name><surname>Connolly</surname><given-names>SB</given-names></name><name><surname>Greenan</surname><given-names>MC</given-names></name><name><surname>Higgins</surname><given-names>DF</given-names></name><etal/></person-group><year>2003</year><article-title>Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog.</article-title><source>Kidney Int</source><volume>64</volume><fpage>480</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">12846743</pub-id></citation></ref><ref id="pone.0002278-Ricardo1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ricardo</surname><given-names>SD</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name><name><surname>Johnson</surname><given-names>GD</given-names></name><name><surname>Kaspar</surname><given-names>J</given-names></name><name><surname>Diamond</surname><given-names>JR</given-names></name></person-group><year>1996</year><article-title>Expression of subunits of the metalloendopeptidase meprin in renal cortex in experimental hydronephrosis.</article-title><source>Am J Physiol</source><volume>270</volume><fpage>F669</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">8967345</pub-id></citation></ref><ref id="pone.0002278-Sadlier1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sadlier</surname><given-names>DM</given-names></name><name><surname>Connolly</surname><given-names>SB</given-names></name><name><surname>Kieran</surname><given-names>NE</given-names></name><name><surname>Roxburgh</surname><given-names>S</given-names></name><name><surname>Brazil</surname><given-names>DP</given-names></name><etal/></person-group><year>2004</year><article-title>Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>29670</fpage><lpage>29680</lpage><pub-id pub-id-type="pmid">15033991</pub-id></citation></ref><ref id="pone.0002278-Berthier1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berthier</surname><given-names>CC</given-names></name><name><surname>Lods</surname><given-names>N</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>van Kooten</surname><given-names>C</given-names></name><name><surname>Leppert</surname><given-names>D</given-names></name><etal/></person-group><year>2006</year><article-title>Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.</article-title><source>Kidney Int</source><volume>69</volume><fpage>358</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">16408127</pub-id></citation></ref><ref id="pone.0002278-Martin1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Eynstone</surname><given-names>L</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Steadman</surname><given-names>R</given-names></name></person-group><year>2001</year><article-title>Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix.</article-title><source>J Am Soc Nephrol</source><volume>12</volume><fpage>88</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">11134254</pub-id></citation></ref><ref id="pone.0002278-McMillan1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMillan</surname><given-names>JI</given-names></name><name><surname>Riordan</surname><given-names>JW</given-names></name><name><surname>Couser</surname><given-names>WG</given-names></name><name><surname>Pollock</surname><given-names>AS</given-names></name><name><surname>Lovett</surname><given-names>DH</given-names></name></person-group><year>1996</year><article-title>Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.</article-title><source>J Clin Invest</source><volume>97</volume><fpage>1094</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">8613533</pub-id></citation></ref><ref id="pone.0002278-Asanuma1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asanuma</surname><given-names>K</given-names></name><name><surname>Shirato</surname><given-names>I</given-names></name><name><surname>Ishidoh</surname><given-names>K</given-names></name><name><surname>Kominami</surname><given-names>E</given-names></name><name><surname>Tomino</surname><given-names>Y</given-names></name></person-group><year>2002</year><article-title>Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes.</article-title><source>Kidney Int</source><volume>62</volume><fpage>822</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">12164864</pub-id></citation></ref><ref id="pone.0002278-Marti2"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marti</surname><given-names>HP</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Kashgarian</surname><given-names>M</given-names></name><name><surname>Lovett</surname><given-names>DH</given-names></name></person-group><year>1994</year><article-title>Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase.</article-title><source>Am J Pathol</source><volume>144</volume><fpage>82</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8291614</pub-id></citation></ref><ref id="pone.0002278-Floege1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floege</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Gordon</surname><given-names>K</given-names></name><name><surname>Iida</surname><given-names>H</given-names></name><name><surname>Pritzl</surname><given-names>P</given-names></name><etal/></person-group><year>1991</year><article-title>Increased synthesis of extracellular matrix in mesangial proliferative nephritis.</article-title><source>Kidney Int</source><volume>40</volume><fpage>477</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">1686288</pub-id></citation></ref><ref id="pone.0002278-Salant1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salant</surname><given-names>DJ</given-names></name><name><surname>Quigg</surname><given-names>RJ</given-names></name><name><surname>Cybulsky</surname><given-names>AV</given-names></name></person-group><year>1989</year><article-title>Heymann nephritis: mechanisms of renal injury.</article-title><source>Kidney Int</source><volume>35</volume><fpage>976</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">2651774</pub-id></citation></ref><ref id="pone.0002278-Kerjaschki1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerjaschki</surname><given-names>D</given-names></name><name><surname>Farquhar</surname><given-names>MG</given-names></name></person-group><year>1983</year><article-title>Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.</article-title><source>J Exp Med</source><volume>157</volume><fpage>667</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">6337231</pub-id></citation></ref><ref id="pone.0002278-Kerjaschki2"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerjaschki</surname><given-names>D</given-names></name><name><surname>Miettinen</surname><given-names>A</given-names></name><name><surname>Farquhar</surname><given-names>MG</given-names></name></person-group><year>1987</year><article-title>Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.</article-title><source>J Exp Med</source><volume>166</volume><fpage>109</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">2885390</pub-id></citation></ref><ref id="pone.0002278-Heymann1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heymann</surname><given-names>W</given-names></name><name><surname>Hackel</surname><given-names>DB</given-names></name><name><surname>Harwood</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>SG</given-names></name><name><surname>Hunter</surname><given-names>JL</given-names></name></person-group><year>1959</year><article-title>Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions.</article-title><source>Proc Soc Exp Biol Med</source><volume>100</volume><fpage>660</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">13645677</pub-id></citation></ref><ref id="pone.0002278-Kerjaschki3"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerjaschki</surname><given-names>D</given-names></name><name><surname>Neale</surname><given-names>TJ</given-names></name></person-group><year>1996</year><article-title>Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).</article-title><source>J Am Soc Nephrol</source><volume>7</volume><fpage>2518</fpage><lpage>2526</lpage><pub-id pub-id-type="pmid">8989729</pub-id></citation></ref><ref id="pone.0002278-Floege2"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floege</surname><given-names>J</given-names></name><name><surname>Eng</surname><given-names>E</given-names></name><name><surname>Young</surname><given-names>BA</given-names></name><name><surname>Couser</surname><given-names>WG</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name></person-group><year>1993</year><article-title>Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.</article-title><source>Kidney Int</source><volume>43</volume><fpage>369</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">8441232</pub-id></citation></ref><ref id="pone.0002278-SteinmannNiggli1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steinmann-Niggli</surname><given-names>K</given-names></name><name><surname>Ziswiler</surname><given-names>R</given-names></name><name><surname>Kung</surname><given-names>M</given-names></name><name><surname>Marti</surname><given-names>HP</given-names></name></person-group><year>1998</year><article-title>Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.</article-title><source>J Am Soc Nephrol</source><volume>9</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">9513901</pub-id></citation></ref><ref id="pone.0002278-Bond3"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>JS</given-names></name><name><surname>Beynon</surname><given-names>RJ</given-names></name></person-group><year>1986</year><article-title>Meprin: a membrane-bound metallo-endopeptidase.</article-title><source>Curr Top Cell Regul</source><volume>28</volume><fpage>263</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">3539535</pub-id></citation></ref><ref id="pone.0002278-Le1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>Q</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Cortez</surname><given-names>S</given-names></name><name><surname>Baricos</surname><given-names>W</given-names></name></person-group><year>1991</year><article-title>A novel metalloproteinase present in freshly isolated rat glomeruli.</article-title><source>Am J Physiol</source><volume>260</volume><fpage>F555</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">1901457</pub-id></citation></ref><ref id="pone.0002278-Kamata1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamata</surname><given-names>K</given-names></name><name><surname>Baird</surname><given-names>LG</given-names></name><name><surname>Erikson</surname><given-names>ME</given-names></name><name><surname>Collins</surname><given-names>AB</given-names></name><name><surname>McCluskey</surname><given-names>RT</given-names></name></person-group><year>1985</year><article-title>Characterization of antigens and antibody specificities involved in Heymann nephritis.</article-title><source>J Immunol</source><volume>135</volume><fpage>2400</fpage><lpage>2408</lpage><pub-id pub-id-type="pmid">2411795</pub-id></citation></ref><ref id="pone.0002278-Farquhar1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farquhar</surname><given-names>MG</given-names></name><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Kerjaschki</surname><given-names>D</given-names></name><name><surname>Orlando</surname><given-names>RA</given-names></name></person-group><year>1995</year><article-title>The Heymann nephritis antigenic complex: megalin (gp330) and RAP.</article-title><source>J Am Soc Nephrol</source><volume>6</volume><fpage>35</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">7579068</pub-id></citation></ref><ref id="pone.0002278-Harvey1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>SJ</given-names></name><name><surname>Jarad</surname><given-names>G</given-names></name><name><surname>Cunningham</surname><given-names>J</given-names></name><name><surname>Rops</surname><given-names>AL</given-names></name><name><surname>van der Vlag</surname><given-names>J</given-names></name><etal/></person-group><year>2007</year><article-title>Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity.</article-title><source>Am J Pathol</source><volume>171</volume><fpage>139</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">17591961</pub-id></citation></ref><ref id="pone.0002278-Mundel1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mundel</surname><given-names>P</given-names></name><name><surname>Shankland</surname><given-names>SJ</given-names></name></person-group><year>1999</year><article-title>Glomerular podocytes and adhesive interaction with glomerular basement membrane.</article-title><source>Exp Nephrol</source><volume>7</volume><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">10213869</pub-id></citation></ref><ref id="pone.0002278-Lahdenkari1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lahdenkari</surname><given-names>AT</given-names></name><name><surname>Lounatmaa</surname><given-names>K</given-names></name><name><surname>Patrakka</surname><given-names>J</given-names></name><name><surname>Holmberg</surname><given-names>C</given-names></name><name><surname>Wartiovaara</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.</article-title><source>J Am Soc Nephrol</source><volume>15</volume><fpage>2611</fpage><lpage>2618</lpage><pub-id pub-id-type="pmid">15466265</pub-id></citation></ref><ref id="pone.0002278-Abbate1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbate</surname><given-names>M</given-names></name><name><surname>Remuzzi</surname><given-names>G</given-names></name></person-group><year>2003</year><article-title>Renoprotection: clues from knockout models of rare diseases.</article-title><source>Kidney Int</source><volume>63</volume><fpage>764</fpage><lpage>766</lpage><pub-id pub-id-type="pmid">12631146</pub-id></citation></ref><ref id="pone.0002278-Craig1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>SS</given-names></name><name><surname>Reckelhoff</surname><given-names>JF</given-names></name><name><surname>Bond</surname><given-names>JS</given-names></name></person-group><year>1987</year><article-title>Distribution of meprin in kidneys from mice with high- and low-meprin activity.</article-title><source>Am J Physiol</source><volume>253</volume><fpage>C535</fpage><lpage>C540</lpage><pub-id pub-id-type="pmid">3310653</pub-id></citation></ref><ref id="pone.0002278-Shankland1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shankland</surname><given-names>SJ</given-names></name><name><surname>Pippin</surname><given-names>J</given-names></name><name><surname>Pichler</surname><given-names>RH</given-names></name><name><surname>Gordon</surname><given-names>KL</given-names></name><name><surname>Friedman</surname><given-names>S</given-names></name><etal/></person-group><year>1996</year><article-title>Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy.</article-title><source>Kidney Int</source><volume>50</volume><fpage>116</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">8807580</pub-id></citation></ref><ref id="pone.0002278-Baker1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>PJ</given-names></name><name><surname>Ochi</surname><given-names>RF</given-names></name><name><surname>Schulze</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Campbell</surname><given-names>C</given-names></name><etal/></person-group><year>1989</year><article-title>Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.</article-title><source>Am J Pathol</source><volume>135</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">2672823</pub-id></citation></ref><ref id="pone.0002278-BeckerPauly1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker-Pauly</surname><given-names>C</given-names></name><name><surname>Howel</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>T</given-names></name><name><surname>Vlad</surname><given-names>A</given-names></name><name><surname>Aufenvenne</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>The alpha and beta subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation.</article-title><source>J Invest Dermatol</source><volume>127</volume><fpage>1115</fpage><lpage>1125</lpage><pub-id pub-id-type="pmid">17195012</pub-id></citation></ref><ref id="pone.0002278-Lottaz1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lottaz</surname><given-names>D</given-names></name><name><surname>Hahn</surname><given-names>D</given-names></name><name><surname>Muller</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name><name><surname>Sterchi</surname><given-names>EE</given-names></name></person-group><year>1999</year><article-title>Secretion of human meprin from intestinal epithelial cells depends on differential expression of the alpha and beta subunits.</article-title><source>Eur J Biochem</source><volume>259</volume><fpage>496</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">9914532</pub-id></citation></ref><ref id="pone.0002278-Danscher1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danscher</surname><given-names>G</given-names></name></person-group><year>1981</year><article-title>Localization of gold in biological tissue. A photochemical method for light and electronmicroscopy.</article-title><source>Histochemistry</source><volume>71</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">6785260</pub-id></citation></ref><ref id="pone.0002278-Sato1"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name></person-group><year>1968</year><article-title>A modified method for lead staining of thin sections.</article-title><source>J Electron Microsc (Tokyo)</source><volume>17</volume><fpage>158</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">4177281</pub-id></citation></ref><ref id="pone.0002278-Eldering1"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eldering</surname><given-names>JA</given-names></name><name><surname>Grunberg</surname><given-names>J</given-names></name><name><surname>Hahn</surname><given-names>D</given-names></name><name><surname>Croes</surname><given-names>HJ</given-names></name><name><surname>Fransen</surname><given-names>JA</given-names></name><etal/></person-group><year>1997</year><article-title>Polarised expression of human intestinal N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase (human meprin) alpha and beta subunits in Madin-Darby canine kidney cells.</article-title><source>Eur J Biochem</source><volume>247</volume><fpage>920</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">9288916</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by grants from the SNF to EES (3100A0-100772) and HPM (No. 3200B0-100429 and 3200B0-114054/1 resp.). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 